HBK Investments’s Medline Inc MDLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.8M Sell
325,000
-100,000
-24% -$4.03M 0.13% 75
2026
Q1
$18.9M Buy
425,000
+190,000
+81% +$8.39M 0.19% 53
2025
Q4
$9.87M Buy
+235,000
New +$9.92M 0.08% 85

Other funds holding MDLN

HBK Investments's MDLN Position: Q2 2026 in Review

HBK Investments reduced its Medline Inc (MDLN) stake by 24% in Q2 2026, selling an estimated $4.03M and leaving 325,000 shares worth $12.8M. The position accounts for 0.13% of the portfolio, ranked #75.

HBK Investments first reported a position in MDLN in Q4 2025 and has held it in 3 quarters since. The position peaked at $18.9M in Q1 2026. 406 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

  • HBK Investments held 325,000 shares of Medline Inc worth $12.8M as of Q2 2026.
  • HBK Investments sold 100,000 Medline Inc shares in Q2 2026, an estimated $4.03M.
  • Medline Inc made up 0.13% of HBK Investments's portfolio in Q2 2026, its #75 holding.
  • HBK Investments first reported a position in Medline Inc in Q4 2025 and has held it in 3 quarters since.
  • HBK Investments's Medline Inc position peaked at $18.9M in Q1 2026.
  • 406 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on HBK Investments's 13F filing for Q2 2026, filed 14 Aug 2026.